Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

12.23
Delayed Data
As of Aug 26
 +0.13 / +1.07%
Today’s Change
6.00
Today|||52-Week Range
13.18
+16.92%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 19.50, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a +59.44% increase from the last price of 12.23.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$8.4M
Reporting Date
Oct 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.15%
 
 
 
 
 
 
Growthannually -33.68%
 
 
 
 
 
 

Sales

Growthquarterly 45.48%
 
 
 
 
 
 
Growthannually 5.11%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.